Protective Effects of an Obesity-Associated Polymorphism (CDKAL1 rs9356744) on Prediabetes: The Cardiometabolic Risk in Chinese (CRC) Study

Abstract

Background Obesity is strongly associated with insulin resistance and elevated plasma glucose levels. The rs9356744 polymorphism in the CDKAL1 gene is associated with body mass index (BMI) only in East Asians. Here, we examined the effect of the rs9356744 polymorphism on glucose-related traits and prediabetes in Chinese adults.

Methods A total of 2 357 participants were enrolled from the Cardiometabolic Risk in Chinese (CRC) Study, including 499 persons with prediabetes, 204 persons with type 2 diabetes, and 1 654 normoglycemic controls. The rs9356744 polymorphism in CDKAL1 was genotyped and analyzed in all participants.

Results Despite the positive relationship between obesity and glucose traits, the T allele of rs9356744, which is associated with a predisposition to obesity, was correlated with lower levels of 2-h oral glucose tolerance test (OGTT) plasma glucose (2hPG) (β=− 0.2104 and P=0.0233), glycated hemoglobin (HbA1c) (β=− 0.0551 and P=0.0298) and higher levels of homeostasis model of assessment β-cell function (HOMA-B) (β=5.282 and P=0.0424). After further adjustment for BMI, the levels of HOMA-B maintained a similar increased trend across rs9356744 genotype (β=3.277 and P=0.1958). In stratified analyses, the associations of rs9356744 with 2hPG and HbA1c were significant for individuals with a low BMI. Moreover, an antagonism action of BMI and rs9356744 on 2hPG (P for interaction=0.0055) was observed. In addition, we found a protective effect of rs9356744 on prediabetes.

Conclusions The CDKAL1 rs9356744 T allele associated with a predisposition to obesity showed a protective effect on HbA1c, 2hPG, and prediabetes. BMI was mediator of the association between the genetic variant and HbA1c, 2hPG, and prediabetes.

Key words

CDKAL1 - rs9356744 - prediabetes - body mass index

^* Authors contributed equally

• References

• 1 Cruz M, Valladares-Salgado A, Garcia-Mena J. et al. Candidate gene association study conditioning on individual ancestry in persons with type 2 diabetes and metabolic syndrome from Mexico City. Diabetes Metab Res Rev 2010; 26: 261-270
• 2 van Hoek M, Dehghan A, Witteman JC. et al. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 2008; 57: 3122-3128
• 3 Tabák AG, Herder C, Rathmann W. et al. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379: 2279-2290
• 4 Yuce S, Cure E, Sezgin H. et al. Has the Required Importance Been given to the Diagnosis and Treatment of Prediabetes?. Int J Prev Med 2014; 5: 1071-1072
• 5 Wen W, Cho YS, Zheng W. et al. Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet 2012; 44: 307-3011
• 6 Okamura T, Yanobu-Takanashi R, Takeuchi F. et al. Deletion of CDKAL1 affects high-fat diet-induced fat accumulation and glucose-stimulated insulin secretion inmice, indicating relevance to diabetes. PLoS One 2012; 7: e49055
• 7 Okada Y, Kubo M, Ohmiya H. et al. Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations. Nat Genet 2012; 44: 302-306
• 8 Consultation, W . Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland: World Health Organization; 1999. 31 1-59
• 9 Yao L, Herlea-Pana O, Heuser-Baker J. et al. Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease. J Immunol Res 2014; 2014: 181450
• 10 Boffetta P, McLerran D, Chen Y. et al. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One 2011; 6: e19930
• 11 Sorisky A. A new predictor for type 2 diabetes?. CMAJ 2008; 178: 313-315
• 12 Carey VJ, Walters EE, Colditz GA. et al. Body Fat distribution and risk of Non-insulin-dependent diabetes mellitus in women. Am J Epidemiol 1997; 145: 614-619
• 13 Rask-Andersen M, Philippot G, Moschonis G. et al. CDKAL1-related single nucleotide polymorphisms are associated with insulin resistance in a cross-sectional cohort of Greek children. PLoS One 2014; 9: e93193
• 14 Brambillasca S, Altkrueger A, Colombo SF. et al. CDK5 regulatory subunit-associated protein 1-like 1 (CDKAL1) is a tailanchored protein in the endoplasmic reticulum (ER) of insulinoma cells. J Biol Chem 2012; 287: 41808-41819
• 15 Ohara-Imaizumi M, Yoshida M, Aoyagi K. et al. Deletion of CDKAL1 affects mitochondrial ATP generation and first-phase insulin exocytosis. PLoS One 2010; 5: e15553
• 16 Wei FY, Nagashima K, Ohshima T. et al. Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat Med 2005; 11: 1104-1108
• 17 Li YY, Wang LS, Lu XZ. et al. CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: a meta-analysis of 62,567 subjects. Sci Rep 2013; 3: 3131
• 18 Lew J, Huang QQ, Qi Z. et al. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994; 371: 423-426
• 19 Ubeda M, Rukstalis JM, Habener JF. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J Biol Chem 2006; 281: 28858-28864
• 20 He M, Cornelis MC, Franks PW. et al. Obesity genotype score and cardiovascular risk in women with type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2010; 30: 327-332
• 21 Robiou-du-Pont S, Bonnefond A, Yengo L. et al. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type2 diabetes risk in the French population. Int J Obes (Lond) 2013; 37: 980-985
• 22 Sanada H, Yokokawa H, Yoneda M. et al. High body mass index is an important risk factor for the development of type 2 diabetes. Intern Med 2012; 51: 1821-1826
• 23 Jørgensen ME, Borch-Johnsen K, Stolk R. et al. Fat distribution and glucose intolerance among Greenland Inuit. Diabetes Care 2013; 36: 2988-2994